Dr. Cameron Gray is Investment Banker at MDB Capital since 2013, and sits on the Boards of Cue Biopharma and Provention Bio. Cameron has a Ph.D. in biophysics and a J.D. Dr. Gray was a hedge fund trader prior to returning to law school. Before joining MDB Capital in 2013, Dr. Gray held senior roles at a fintech company in the community banking sector. After receiving his J.D., Dr. Gray led the early development of IPXI, a financial exchange spun out of Ocean Tomo in Chicago. Dr. Gray also ran Asia Pacific for ICAP’s Patent Brokerage business.
Dr. Gray has lived in the Bay Area since 2010.